Contineum Therapeutics, Inc. (CTNM) — Dilution Risk Analysis

Current Snapshot

Contineum Therapeutics, Inc. (CTNM) has a DilutionWatch score of 32/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
23,099,173 Source
Public Float
27,594,511 Source
Float as % of Outstanding
119.5%

Dilution Risk Score

Score: 32/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

1 shelf registration or ATM offering filing detected in recent history.

Recent filing forms in the source payload: 8-K 1, 424B5 1, 4 8.

FormFiledAccession
8-K 2026-03-05 0001628280-26-015159
424B5 2026-03-05 0001628280-26-015205
4 2026-03-02 0001437749-26-006421
4 2026-03-02 0001437749-26-006422
4 2026-02-26 0001437749-26-005889
4 2026-02-26 0001437749-26-005892
4 2026-02-20 0001437749-26-004912
4 2026-02-13 0001437749-26-004122
4 2026-02-13 0001437749-26-004126
4 2026-01-30 0001437749-26-002575

Dilution Risk Drivers

DriverStored ValueSource
ATM offering capacity remaining $100,000,000 Source
Cash runway 64 months Source
Three-year share count growth 38.18% Source

DilutionWatch Analysis

Risk Level
MEDIUM (Score: 32/10) Source
Cash Runway
64 months Source
ATM Offering Capacity Remaining
$100,000,000 Source
Share Count Growth (3-Year)
38.18% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.